CDKN2A/B mutations and allele-specific alterations stratify survival outcomes in IDH-mutant astrocytomas

Affiliations

• ¹ Human Oncology and Pathogenesis Program, Sloan Kettering Institute, New York, NY, 10065, USA.
• ² Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
• ³ Murtha Cancer Center Research Program, Uniformed Services of the Health Sciences, Bethesda, MD, 20817, USA.
• ⁴ Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD, 20817, USA.
• ⁵ Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
• ⁶ Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
• ⁷ Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
• ⁸ Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. balet@mskcc.org.